Northern Trust
RCEL icon

Northern Trust’s Avita Medical RCEL Stock Holding History

Northern Trust’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Sell
68,973
-114,208
-62% -$493K ﹤0.01% 3825
2026
Q1 		$678K Buy
183,181
+19,778
+12% +$83K ﹤0.01% 3492
2025
Q4 		$564K Sell
163,403
-9,375
-5% -$37.4K ﹤0.01% 3616
2025
Q3 		$883K Sell
172,778
-86,819
-33% -$453K ﹤0.01% 3453
2025
Q2 		$1.37M Sell
259,597
-10,114
-4% -$73.6K ﹤0.01% 3213
2025
Q1 		$2.2M Buy
269,711
+40,991
+18% +$383K ﹤0.01% 2875
2024
Q4 		$2.93M Buy
228,720
+12,253
+6% +$145K ﹤0.01% 2809
2024
Q3 		$2.32M Buy
216,467
+3,236
+2% +$30.4K ﹤0.01% 2911
2024
Q2 		$1.69M Sell
213,231
-4,903
-2% -$46.6K ﹤0.01% 2991
2024
Q1 		$3.5M Sell
218,134
-7,046
-3% -$114K ﹤0.01% 2689
2023
Q4 		$3.09M Buy
225,180
+6,576
+3% +$75.4K ﹤0.01% 2759
2023
Q3 		$3.19M Buy
218,604
+700
+0.3% +$11.8K ﹤0.01% 2685
2023
Q2 		$3.71M Buy
217,904
+173,868
+395% +$2.55M ﹤0.01% 2663
2023
Q1 		$615K Buy
44,036
+64
+0.1% +$681 ﹤0.01% 3375
2022
Q4 		$290K Hold
43,972
– – ﹤0.01% 3702
2022
Q3 		$232K Sell
43,972
-5
-0% -$31 ﹤0.01% 3814
2022
Q2 		$209K Sell
43,977
-172,749
-80% -$1.07M ﹤0.01% 3901
2022
Q1 		$1.84M Sell
216,726
-12,083
-5% -$111K ﹤0.01% 3142
2021
Q4 		$2.74M Buy
228,809
+3,431
+2% +$52.3K ﹤0.01% 3061
2021
Q3 		$3.99M Sell
225,378
-9,464
-4% -$179K ﹤0.01% 2872
2021
Q2 		$4.82M Buy
234,842
+194,160
+477% +$3.83M ﹤0.01% 2863
2021
Q1 		$806K Buy
40,682
+2,094
+5% +$48.7K ﹤0.01% 3671
2020
Q4 		$717K Buy
+38,588
New +$846K ﹤0.01% 3625

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust's RCEL Position: Q2 2026 in Review

Northern Trust reduced its Avita Medical (RCEL) stake by 62% in Q2 2026, selling an estimated $493K and leaving 68,973 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #3825.

Northern Trust first reported a position in RCEL in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.82M in Q2 2021. 74 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Northern Trust held 68,973 shares of Avita Medical worth $285K as of Q2 2026.
  • Northern Trust sold 114,208 Avita Medical shares in Q2 2026, an estimated $493K.
  • Avita Medical made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3825 holding.
  • Northern Trust first reported a position in Avita Medical in Q4 2020 and has held it in 23 quarters since.
  • Northern Trust's Avita Medical position peaked at $4.82M in Q2 2021.
  • 74 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.